Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation-Reference-Cited by-同舟云学术

Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

Published:2021-04-16 Issue:9 Volume:56 Page:2108-2117
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Percival Mary-Elizabeth^ORCID,Wang Hai-Lin,Zhang Mei-Jie,Saber Wael,de Lima Marcos^ORCID,Litzow Mark,Kebriaei Partow^ORCID,Abdel-Azim Hisham,Adekola Kehinde,Aljurf Mahmoud,Bacher Ulrike,Badawy Sherif M.,Beitinjaneh Amer,Bejanyan Nelli^ORCID,Bhatt Vijaya^ORCID,Byrne Michael,Cahn Jean-Yves,Castillo Paul^ORCID,Chao Nelson,Chhabra Saurabh^ORCID,Copelan Edward,Cutler Corey,DeFilipp Zachariah^ORCID,Dias Ajoy,Diaz Miguel Angel,Estey Elihu,Farhadfar Nosha,Frangoul Haydar A.,Freytes César O.,Gale Robert Peter,Ganguly Siddhartha,Gowda Lohith,Grunwald Michael^ORCID,Hossain Nasheed^ORCID,Kamble Rammurti T.,Kanakry Christopher G.,Kansagra Ankit^ORCID,Kharfan-Dabaja Mohamed A.^ORCID,Krem Maxwell,Lazarus Hillard M.^ORCID,Lee Jong Wook,Liesveld Jane L.,Lin Richard^ORCID,Liu Hongtao,McGuirk Joseph^ORCID,Munker Reinhold,Murthy Hemant S.,Nathan Sunita^ORCID,Nishihori Taiga^ORCID,Olsson Richard F.,Palmisiano Neil,Passweg Jakob R.,Prestidge Tim^ORCID,Ringdén Olov^ORCID,Rizzieri David A.,Rybka Witold B.^ORCID,Savoie Mary Lynn,Schultz Kirk R.^ORCID,Seo Sachiko^ORCID,Sharma Akshay^ORCID,Solh Melhem^ORCID,Strair Roger,van der Poel Marjolein,Verdonck Leo F.,Yared Jean A.^ORCID,Weisdorf Daniel^ORCID,Sandmaier Brenda M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01261-6.pdf

Reference25 articles.

1. Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA. 2009;301:2349–61.

2. Appelbaum FR. Indications for allogeneic hematopoietic cell transplantation for acute myeloid leukemia in the genomic era. Am Soc Clin Oncol Educ Book. 2014;34:e327–33.

3. Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 2017;129:424–47.

4. Chen X, Xie H, Wood BL, Walter RB, Pagel JM, Becker PS, et al. Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia. J Clin Oncol. 2015;33:1258–64.

5. Walter RB, Kantarjian HM, Huang X, Pierce SA, Sun Z, Gundacker HM, et al. Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study. J Clin Oncol. 2010;28:1766–71.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between morphologic remission with or without hematologic recovery and outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia;Bone Marrow Transplantation;2024-08-29

2. Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia;Frontiers in Oncology;2024-05-02

3. Allogeneic transplantation after immunotherapy for relapsed/refractory non-Hodgkin lymphoma: a comparison with a historical cohort;Cytotherapy;2024-05

4. Time to transplantation and pediatric acute myeloid leukemia outcomes;Bone Marrow Transplantation;2022-12-10

5. Allogeneic transplantation for advanced acute leukemia;Hematology;2022-12-09